Loading
Latest filing published 23 Mar 2017 for Echo Therapeutics, Inc..
No signal scores available.
All filings by Shepard M. Goldberg on record concern Echo Therapeutics, Inc. The record holds 2 filings, for trades running from 10 July 2014 to 21 March 2017.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
The latest filing, published on 23 March 2017, reports a share grant in Echo Therapeutics, Inc. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations